UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Pre-Messinian (Sub-Salt) Source-Rock Potential on Back-Stop Basins of the Hellenic Trench System (Messara Basin, Central Crete, Greece)

Oil & gas science and technology, 2016-01, Vol.71 (1), p.6

2016

Volltextzugriff (PDF)

Patient accessible electronic health records: exploring recommendations for successful implementation strategies

Journal of medical Internet research, 2008-10, Vol.10 (4), p.e34-e34

2008

Volltextzugriff (PDF)

Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3338-3345

2009

Volltextzugriff (PDF)

Toronto Addis Ababa Academic Collaboration: A Relational, Partnership Model for Building Educational Capacity Between a High- and Low-Income University

Academic medicine, 2018-12, Vol.93 (12), p.1795-1801

2018

Volltextzugriff (PDF)

Medical Student Perspectives on the Impact of Experiential Learning As Volunteer Stem Cell Donor Recruiters on Their Development As Physicians

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S309-S310

2021

Volltextzugriff (PDF)

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

British journal of haematology, 2012-10, Vol.159 (1), p.39-49

2012

Volltextzugriff (PDF)

Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma

British journal of haematology, 2019-02, Vol.184 (3), p.469-472

2019

Volltextzugriff (PDF)

Evaluation of direct medical costs of hospitalization for febrile neutropenia

Cancer, 2010-02, Vol.116 (3), p.742-748

2010

Volltextzugriff (PDF)

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study

Leukemia & lymphoma, 2019-03, Vol.60 (4), p.912-919

2019

Volltextzugriff (PDF)

Survival of patients with transformed lymphoma in the rituximab era

Annals of hematology, 2014-06, Vol.93 (6), p.1007-1014

2014

Volltextzugriff (PDF)

Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis

Leukemia & lymphoma, 2014-11, Vol.55 (11), p.2502-2507

2014

Volltextzugriff (PDF)

Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan

Blood, 2016-12, Vol.128 (22), p.1794-1794

2016

Volltextzugriff (PDF)

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab

Annals of hematology, 2015-05, Vol.94 (5), p.813-823

2015

Volltextzugriff (PDF)

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Blood, 2017-12, Vol.130, p.4069-4069

2017

Volltextzugriff (PDF)

Intravascular large B cell lymphoma presenting as transient erythema nodosum-like lesions and fever

The American journal of medicine, 2017-03, Vol.130 (3), p.e103-e104

2017

Volltextzugriff (PDF)

Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study

Clinical lymphoma, myeloma and leukemia, 2016, Vol.16 (1), p.18-28.e4

2016

Volltextzugriff (PDF)

Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase

The European respiratory journal, 2007-11, Vol.30 (5), p.1014-1017

2007

Volltextzugriff (PDF)

A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8551-8551

2014

Volltextzugriff (PDF)

Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study

Hematological oncology, 2018-08, Vol.36 (3), p.525-532

2018

Volltextzugriff (PDF)

Sustained Immune Competency and Long Term Molecular Remissions in FL Patients with FLIPI Risk Factors >1, Treated Front Line with R-CHOP Followed by Consolidative 90 Y-Radioimmunotherapy and Maintenance Rituximab

Blood, 2012-11, Vol.120 (21), p.3681-3681

2012

Volltextzugriff (PDF)

PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α

Hematological oncology, 2017-06, Vol.35 (S2), p.365-366

2017

Volltextzugriff (PDF)

Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study

Hematological oncology, 2018-04, Vol.36 (3), p.525-532

2018

Volltextzugriff (PDF)

Effect of a rituximab-based regimen on the incidence of CNS relapse in patients with diffuse large B-cell lymphoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8098-8098

2010

Volltextzugriff (PDF)

First Evidence for High Incidence of Complete and Sustained Molecular Remissions and Maintenance of Immune Responses in Patients Receiving Consolidation with Y90 Ibritumomab Tiuxetan (90Y-RIT) Post R-CHOP for Newly Diagnosed Advanced Stage High and Intermediate Risk Follicular Lymphoma

Blood, 2011-11, Vol.118 (21), p.2701-2701

2011

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(48)
Dissertationen
(2)

Sprache

Englisch
(50)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Humans
(14)
Life Sciences & Biomedicine
(14)
Female
(10)
Male
(10)
Middle Aged
(8)
Hematology
(7)
Oncology
(7)
Rituximab
(7)
Adult
(5)
Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
Disease-Free Survival
(4)
Follicular Lymphoma
(4)
Hematology, Oncology And Palliative Medicine
(4)
Immunotherapy
(4)
Medical Sciences
(4)
Aged, 80 And Over
(3)
Antibodies, Monoclonal, Murine-Derived - Administration & Dosage
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pre-Messinian (Sub-Salt) Source-Rock Potential on Back-Stop Basins of the Hellenic Trench System (Messara Basin, Central Crete, Greece)

Patient accessible electronic health records: exploring recommendations for successful implementation strategies

Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors

Toronto Addis Ababa Academic Collaboration: A Relational, Partnership Model for Building Educational Capacity Between a High- and Low-Income University

Medical Student Perspectives on the Impact of Experiential Learning As Volunteer Stem Cell Donor Recruiters on Their Development As Physicians

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature

Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma

Evaluation of direct medical costs of hospitalization for febrile neutropenia

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study

Survival of patients with transformed lymphoma in the rituximab era

Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis

Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Intravascular large B cell lymphoma presenting as transient erythema nodosum-like lesions and fever

A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma: Canadian Cancer Trials Group Study LY.15

Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study

Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase

A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas

Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study

Sustained Immune Competency and Long Term Molecular Remissions in FL Patients with FLIPI Risk Factors >1, Treated Front Line with R-CHOP Followed by Consolidative 90 Y-Radioimmunotherapy and Maintenance Rituximab

PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α

Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with 90 Y ibritumomab tiuxetan in a phase II study

Effect of a rituximab-based regimen on the incidence of CNS relapse in patients with diffuse large B-cell lymphoma

First Evidence for High Incidence of Complete and Sustained Molecular Remissions and Maintenance of Immune Responses in Patients Receiving Consolidation with Y90 Ibritumomab Tiuxetan (90Y-RIT) Post R-CHOP for Newly Diagnosed Advanced Stage High and Intermediate Risk Follicular Lymphoma

Suchergebnisse filtern